{"id":100073,"date":"2022-05-02T14:22:47","date_gmt":"2022-05-02T07:22:47","guid":{"rendered":"https:\/\/www.nstda.or.th\/openarchive\/?post_type=tnc_col_2494_item&#038;p=100073"},"modified":"2023-02-15T15:07:24","modified_gmt":"2023-02-15T08:07:24","slug":"anti-cancer-effect-of-engineered-recombinant-interleukin-18","status":"publish","type":"tnc_col_2494_item","link":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/","title":{"rendered":"Anti-cancer effect of engineered recombinant interleukin 18"},"content":{"rendered":"","protected":false},"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","format":"standard","class_list":["post-100073","tnc_col_2494_item","type-tnc_col_2494_item","status-publish","format-standard","hentry","tnc_tax_11166-medical-biotechnology","tnc_tax_11164-clinical-medicine","tnc_tax_11162-biological-sciences","tnc_tax_11156-agriculture-forestry-fishing-and-hunting","tnc_tax_11150-animal-cell","tnc_tax_11150-animal-experiment","tnc_tax_11150-animal-model","tnc_tax_11150-animal-tissue","tnc_tax_11150-antineoplastic-activity","tnc_tax_11150-antineoplastic-agent","tnc_tax_11150-interleukin-18","tnc_tax_11150-interleukin-2","tnc_tax_11150-recombinant-interleukin-18","tnc_tax_11150-recombinant-protein","tnc_tax_2222-anti-cancer-immunity","tnc_tax_2222-ctl","tnc_tax_2222-in-vivo","tnc_tax_2222-interleukin-18","tnc_tax_2222-th1"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anti-cancer effect of engineered recombinant interleukin 18 - NSTDA Open Repository<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anti-cancer effect of engineered recombinant interleukin 18 - NSTDA Open Repository\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/\" \/>\n<meta property=\"og:site_name\" content=\"NSTDA Open Repository\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-15T08:07:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t<meta property=\"og:image:height\" content=\"625\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/\",\"url\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/\",\"name\":\"Anti-cancer effect of engineered recombinant interleukin 18 - NSTDA Open Repository\",\"isPartOf\":{\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#website\"},\"datePublished\":\"2022-05-02T07:22:47+00:00\",\"dateModified\":\"2023-02-15T08:07:24+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.nstda.or.th\/openarchive\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NSTDA's Research Publications\",\"item\":\"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Anti-cancer effect of engineered recombinant interleukin 18\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#website\",\"url\":\"https:\/\/www.nstda.or.th\/openarchive\/\",\"name\":\"NSTDA Open Repository\",\"description\":\"NSTDA Open Repository is a digital open-access repository for NSTDA&#039;s research publications, including manuscripts, journal articles conference papers, reviews, and more. The publications are made available in the Repository on terms of Creative Commons License. You may read, download, share, and re-use for your research as long as you abide by the license under which an item has been released.\",\"publisher\":{\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.nstda.or.th\/openarchive\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#organization\",\"name\":\"National Science and Technology Development Agency\",\"url\":\"https:\/\/www.nstda.or.th\/openarchive\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png\",\"contentUrl\":\"http:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png\",\"width\":2000,\"height\":625,\"caption\":\"National Science and Technology Development Agency\"},\"image\":{\"@id\":\"https:\/\/www.nstda.or.th\/openarchive\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anti-cancer effect of engineered recombinant interleukin 18 - NSTDA Open Repository","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/","og_locale":"en_US","og_type":"article","og_title":"Anti-cancer effect of engineered recombinant interleukin 18 - NSTDA Open Repository","og_url":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/","og_site_name":"NSTDA Open Repository","article_modified_time":"2023-02-15T08:07:24+00:00","og_image":[{"width":2000,"height":625,"url":"https:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/","url":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/","name":"Anti-cancer effect of engineered recombinant interleukin 18 - NSTDA Open Repository","isPartOf":{"@id":"https:\/\/www.nstda.or.th\/openarchive\/#website"},"datePublished":"2022-05-02T07:22:47+00:00","dateModified":"2023-02-15T08:07:24+00:00","breadcrumb":{"@id":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/anti-cancer-effect-of-engineered-recombinant-interleukin-18\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.nstda.or.th\/openarchive\/"},{"@type":"ListItem","position":2,"name":"NSTDA's Research Publications","item":"https:\/\/www.nstda.or.th\/openarchive\/nstda-research-publications\/"},{"@type":"ListItem","position":3,"name":"Anti-cancer effect of engineered recombinant interleukin 18"}]},{"@type":"WebSite","@id":"https:\/\/www.nstda.or.th\/openarchive\/#website","url":"https:\/\/www.nstda.or.th\/openarchive\/","name":"NSTDA Open Repository","description":"NSTDA Open Repository is a digital open-access repository for NSTDA&#039;s research publications, including manuscripts, journal articles conference papers, reviews, and more. The publications are made available in the Repository on terms of Creative Commons License. You may read, download, share, and re-use for your research as long as you abide by the license under which an item has been released.","publisher":{"@id":"https:\/\/www.nstda.or.th\/openarchive\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nstda.or.th\/openarchive\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.nstda.or.th\/openarchive\/#organization","name":"National Science and Technology Development Agency","url":"https:\/\/www.nstda.or.th\/openarchive\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.nstda.or.th\/openarchive\/#\/schema\/logo\/image\/","url":"http:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png","contentUrl":"http:\/\/www.nstda.or.th\/openarchive\/wp-content\/uploads\/2019\/02\/cropped-cropped-aw-nstda-color-1-1.png","width":2000,"height":625,"caption":"National Science and Technology Development Agency"},"image":{"@id":"https:\/\/www.nstda.or.th\/openarchive\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/tnc_col_2494_item\/100073","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/tnc_col_2494_item"}],"about":[{"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/types\/tnc_col_2494_item"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/comments?post=100073"}],"version-history":[{"count":1,"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/tnc_col_2494_item\/100073\/revisions"}],"predecessor-version":[{"id":109206,"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/tnc_col_2494_item\/100073\/revisions\/109206"}],"wp:attachment":[{"href":"https:\/\/www.nstda.or.th\/openarchive\/wp-json\/wp\/v2\/media?parent=100073"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}